Sorin Group SpA, a Milan based
leader in medical technologies, said Thursday it would merge
with Cyberonics Inc. of the United States in a 2.4-billion euro
deal to create a new entity in the field of devices and
treatments for health conditions. The new operation is to be
based in London, the companies said, where the tax rates is
lower. Sorin shares jumped by 22.13% in trading Thursday morning
on the Milan stock exchange, trading at 2.68 euros.
ALL RIGHTS RESERVED © Copyright ANSA
